{
    "2020-10-08": [
        [
            {
                "time": "2020-10-08",
                "original_text": "Lilly Confirms Date and Conference Call for Third-Quarter 2020 Financial Results Announcement",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Third-Quarter",
                        "Financial Results"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "Covid Report: Regeneron Pharmaceuticals Files For Emergency Authorization; Gilead Inks European Supply Deal",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Emergency Authorization",
                        "Gilead",
                        "Supply Deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "Best COVID Drug Stocks to Buy on Trump Recovery",
                "features": {
                    "keywords": [
                        "COVID",
                        "Drug Stocks",
                        "Trump Recovery"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "Coronavirus Latest: Thursday, October 8",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Thursday",
                        "October 8"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "Regeneron Requests Emergency Use Authorization, Analysts See Coronavirus Antibodies As Earnings Driver In 2021",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Emergency Use Authorization",
                        "Earnings Driver"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "Regeneron needs to provide more data on its antibody therapy: Emergency Physician",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "antibody therapy",
                        "data"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "BUZZ-U.S. STOCKS ON THE MOVE-Occidental Petroleum, Oxbridge Re Holdings, Roku, fuboTV, Beyond Meat",
                "features": {
                    "keywords": [
                        "U.S. Stocks",
                        "Occidental Petroleum",
                        "Oxbridge Re Holdings",
                        "Roku",
                        "fuboTV",
                        "Beyond Meat"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "various"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "Lilly's rheumatoid arthritis drug cuts COVID-19 deaths in trial, data shows",
                "features": {
                    "keywords": [
                        "Lilly",
                        "rheumatoid arthritis drug",
                        "COVID-19",
                        "deaths"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "The Truth About Trump's Covid-19 Cocktail ‘Cure’",
                "features": {
                    "keywords": [
                        "Trump",
                        "Covid-19",
                        "Cocktail Cure"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-08",
                "original_text": "Coronavirus update: Regeneron, Eli Lilly seek FDA approval of antibodies, boosted by Trump's bout with COVID",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Regeneron",
                        "Eli Lilly",
                        "FDA approval",
                        "antibodies"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}